Investing.com - Bausch Health (NYSE: BHC) reported second quarter EPS of $0.07, $0.12 better than the analyst estimate of $-0.05. Revenue for the quarter came in at $2.17B versus the consensus estimate of $2.04B.
Guidance
Bausch Health sees FY 2023 revenue of $8.45B-$8.65B versus the analyst consensus of $8.35B.
Bausch Health's stock price closed at $9.33. It is up 60.03% in the last 3 months and up 82.23% in the last 12 months.
Bausch Health saw 1 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Bausch Health's stock price’s past reactions to earnings here.
According to InvestingPro, Bausch Health's Financial Health score is "good performance".
Check out Bausch Health's recent earnings performance, and Bausch Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar